Skip to main content

Table 1 Demographics and characteristics of Patients, stratified by procedure

From: Left subclavian artery revascularization in thoracic endovascular aortic repair: single center’s clinical experiences from 171 patients

Variables

Overall

Unrevascularized (n = 28)

Revascularized (n = 143)

P1 value

P2 value

CSB(n = 100)

F-TEVAR(n = 43)

Age (years, Mean ± SD)

56.75 ± 12.08

61.20 ± 14.45

55.43 ± 11.86

58.40 ± 10.57

0.254

0.15

Gender (Male, N, %)

147, 86%

24, 85.7%

90, 90%

33, 76.7%

1

0.036*

BMI (Kg/m2, Mean ± SD)

25.58 ± 3.24

25.79 ± 2.79

25.68 ± 3.22

25.28 ± 3.52

0.763

0.523

HTN (N, %)

126, 73.7%

21, 75%

73, 72.0%

33, 76.7%

0.967

0.556

DM (N, %)

12, 7.0%

0, 0%

9, 9.0%

3, 7.0%

0.236

0.943

CAD (N, %)

5, 2.9%

1, 3.6%

2, 2.0%

2, 4.7%

1

0.742

Previous open cardiac surgery (N, %)

9, 5.3%

2, 7.1%

4, 4.0%

3, 7.0%

0.981

0.738

Stroke history (N, %)

13, 7.6%

3, 10.7%

9, 9.0%

1, 2.3%

0.772

0.281

Chronic bronchitis (N, %)

4, 2.3%

1, 3.6%

3, 3.0%

0, 0%

0.514

0.554

CKD (N, %)

12, 7.0%

2, 7.1%

4, 4.0%

6, 14.0%

1

0.075

ESRD (N, %)

8, 4.7%

1, 3.6%

3, 3.0%

4, 9.3%

1

0.238

Smoking (N, %)

51, 29.8%

6, 21.4%

32, 32%

13, 30.2%

0.288

0.835

Hospital days (days, median, IQR)

18 (14–23)

16 (12.25–21)

19 (14–22.75)

18 (14–26)

0.195

0.711

Urgency

    

0.005*

0.521

 Elective (> 24 h, N, %)

160, 93.6%

22, 78.6%

95, 95.0%

43, 100%

  

 Urgent (4–24 h, N, %)

8, 4.7%

4, 14.3%

4, 4.0%

0, 0%

  

 Emergent (< 4 h, N, %)

3, 1.8%

2, 7.1%

1, 1.0%

0, 0%

  

Type of pathology (N, %)

    

0.084

0.607

 Dissection

145, 84.8%

24, 85.7%

84, 84.0%

37, 86.0%

  

 Aneurysm

10, 5.8%

4, 14.3%

5, 5.0%

1, 2.3%

  

 PAU

7, 4.1%

0, 0%

6, 6.0%

1, 2.3%

  

 IMH

9, 5.3%

0

5, 5.0%

4, 9.3%

  
  1. P1 value, unrevascularied versus revascularized
  2. P2 value, CSB versus F-TEVAR
  3. BMI, body mass index; HTN, hypertension; DM, diabetes mellitus; AF, atrial fibrillation; CAD, coronary artery disease; CKD, chronic kidney disease; ESRD, end-stage renal disease; PAU, penetrating aortic ulcers; IMH, intramural hematoma
  4. *Statistically significant values